NCT00482911 2017-03-27Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye MelanomaNational Institutes of Health Clinical Center (CC)Phase 2 Terminated12 enrolled 10 charts